Related Experiment Video
Updated: Dec 11, 2025

09:03
Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET
Published on: October 22, 2019
10.7K
Imaging Fast-Acting Drug Effects in Humans Using 1H-MRS
Tara L White1,2,3, Meghan A Gonsalves4
1Center for Alcohol and Addiction Studies, Brown University, Providence, Rhode Island 02912, United States.
ACS Chemical Neuroscience
|August 26, 2020
Summary
Proton magnetic resonance spectroscopy (¹H-MRS) can now track rapid brain chemistry changes after drug use. This noninvasive imaging technique reveals fast-acting drug effects and neural mechanisms in the human brain.
Area of Science:
- Neuroimaging
- Metabolic Neuroscience
- Pharmacology
Background:
- ¹H-MRS typically assesses long-term brain metabolism changes in disorders and substance dependence.
- Its potential for evaluating rapid, acute drug-induced biochemical alterations is under-explored.
Purpose of the Study:
- To highlight the utility of ¹H-MRS for imaging rapid drug actions in the human brain.
- To explore neural mechanisms underlying fast-acting drug effects on perception, mood, and cognition.
- To present strategies for optimizing ¹H-MRS to study acute drug-induced neurochemical changes.
Main Methods:
- Noninvasive imaging using ¹H-MRS to quantify neurometabolic compounds in vivo.
- Review of existing literature and examples of psychostimulant drug effects.
- Proposal of optimized ¹H-MRS approaches for studying rapid phenomena.
Main Results:
- ¹H-MRS can quantify neurometabolic compounds at millimolar concentrations in the brain.
- The technique has the potential to reveal phasic, in vivo changes in metabolic pathways post-drug exposure.
- Strategies are proposed to enhance ¹H-MRS for imaging acute drug effects.
Conclusions:
- ¹H-MRS is a valuable tool for investigating the neural mechanisms of rapid drug action.
- This technique can provide insights into acute, drug-induced changes in brain biochemistry.
- Optimized ¹H-MRS offers potential for basic research and drug development.

